Home › NDC Lookup › RxCUI directory › RxCUI 997625

Sevoflurane 1000 MG/ML Inhalation Solution [Sojourn] — RxCUI 997625

RxNorm drug concept · Semantic branded drug
RxCUI 997625 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI997625
Official nameSevoflurane 1000 MG/ML Inhalation Solution [Sojourn]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSojourn 100 % Inhalation Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sevoflurane: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sevoflurane is a gas you breathe in through a mask to go completely under for surgery. Anesthesiologists often choose it because it works very quickly — you're typically asleep wit...
  • What exactly is sevoflurane and why would my doctor use it instead of other anesthetics?
  • The most common things people notice after surgery are nausea and vomiting, feeling drowsy or dizzy, and sometimes shivering. Some people — especially children — feel agitated or c...
  • What side effects should I expect after waking up from sevoflurane anesthesia?
📖 Read our full Sevoflurane guide →

🕸️ Concept Web — How Sevoflurane 1000 MG/ML Inhalation Solution [Sojo... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sevoflurane 1000 MG/ML Inhalation Solution [Sojourn] RxCUI 997625

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sevoflurane 36453
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sojourn 997622
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sevoflurane Inhalation Solution 2108407
    • Sevoflurane Inhalant Product 1159080
    • Sevoflurane Inhalation Solution [Sojourn] 2108437
    • Sojourn Inhalant Product 1184812
    • Inhalation Solution 346161
    • Inhalant Product 1151123
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Sevoflurane 1000 MG/ML [Sojourn] SBDC · 997623
  • Sevoflurane Inhalation Solution [Sojourn] SBDF · 2108437
  • Sojourn Inhalant Product SBDG · 1184812
  • Sojourn BN · 997622

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 997625 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
66794-0012-25 250 mL in 1 BOTTLE, GLASS (66794-012-25) Sojourn Piramal Critical Care Inc 2010-04-13
Observed labelers: Piramal Critical Care Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.